One of the most poorly publicised and understood areas of global pharma is falsified and counterfeit medicines. Historically, the focus on this topic has been on low value -... read more →
http://www.bioprocessintl.com/manufacturing/cell-therapies/the-potential-application-of-real‑time-release-testing-for-the-biomanufacture-of-autologous-cell‑based-immunotherapies/ Onco-immunotherapy is arguably the hottest area in biotech. Juno, Bluebird, AdaptImmune, Novartis to name a few, have all placed significant bets. However, manufacturing scale-up and robust business models for... read more →
Fundamentally, IPAV is in the business of accelerating patient cures. Therefore, our team is excited by the opportunities presented by the US 21st Century Cures Act, which positively impacts all... read more →